Home »
Scientists in the city at the center of China’s virus outbreak have applied to patent a drug made by U.S. company Gilead Science Inc. to treat the disease, possibly fueling conflict over technology policy that
All type 2 diabetes patient subgroups are likely to achieve cardiovascular protection from the use of SGLT2 inhibitors, according to a large multi-study review published in the Journal of the American Heart Association. Lead author
Dementia breakthrough as scientists find an existing drug for Parkinson’s can curb psychosis in patients with the memory-robbing disorder Pimavanserin, daily pill sold as Nuplazid, halved the chance of psychosis in study The drug was
Medication prescribed for a certain type of epilepsy may offer a new method for treating malignant infantile brain tumors. A specific mTOR inhibitor has the ability to cross the blood-brain barrier to both reach and
A research team from the School of Chinese Medicine at Hong Kong Baptist University (HKBU) has successfully developed a novel aptamer, i.e. a single-stranded piece of DNA, for the treatment of osteogenesis imperfecta (OI) with
The 2018 federal Right to Try Act allows patients with a life-threatening illness to be treated with drugs that have not yet been approved by the Food and Drug Administration (FDA). Many in the oncology
Demi Lovato revealed on Instagram that her friend Thomas died this week of a drug overdose. She reminded fans that “addiction is NO joke” in her post. Demi has been through her own public struggles
Using a new technique that can identify genetic profiles of individual cells, University of Notre Dame researchers modeled a breast cancer tumor’s potential resistance to a drug, and then identified a drug combination that reversed
Scientists at the University of Birmingham have found an anti-malarial drug was effective in treating head and neck cancer in mice. The drug quinacrine was used extensively to prevent and treat malaria in soldiers fighting
A new clinical trial conducted at The Ohio State University Wexner Medical Center found a cost-effective generic medication works just as well as a more expensive drug in preserving cardiovascular function in boys with Duchenne